Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03319901
Title Venetoclax and Chemotherapy In ALL
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Dana-Farber Cancer Institute
Indications

acute lymphoblastic leukemia

Therapies

Cytarabine

Mercaptopurine

Methotrexate

Cyclophosphamide

Venetoclax

Doxorubicin

Etoposide

Vincristine Sulfate

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.